Aprea Therapeutics (APRE) Other financing activities (2018 - 2021)
Aprea Therapeutics (APRE) posted quarterly Other financing activities of $121397.0 for Q4 2021, little changed quarter-over-quarter from $121426.0 in Q2 2020.
Aprea Therapeutics (APRE) Other financing activities (2018 - 2021) Analysis & Trends
Aprea Therapeutics (APRE) has reported Other financing activities for 4 consecutive years, with $121397.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Other financing activities changed N/A year-over-year to $121397.0; the TTM figure through Dec 2021 stood at $242823.0 (up 60.86% YoY), while the FY2025 annual figure was $91.0, changed N/A from the prior year.
- Other financing activities steadied at $121397.0 in Q4 2021 per APRE's latest filing, from $121426.0 in the prior quarter.
- Across five years, Other financing activities topped out at $121426.0 in Q2 2020 and bottomed at $682.0 in Q4 2018.
- Historically, Other financing activities has averaged $57337.5 across 4 years, with a median of $38701.0 in 2019.
- Annual changes were most pronounced in 2019 — Other financing activities jumped 6920.38% — and 2020, when it grew 27.71%.
- Aprea Therapeutics' Other financing activities stood at $682.0 in 2018, then surged by 6920.38% to $47879.0 in 2019, then soared by 153.61% to $121426.0 in 2020, then dropped by 0.02% to $121397.0 in 2021.
- Business Quant data shows APRE's Other financing activities at $121397.0 in Q4 2021, $121426.0 in Q2 2020, and $29523.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aprea Therapeutics | 34.25 Mn | 34.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 121,397.00 |
| Dec 31, 2021 | 121,397.00 |
| Jun 30, 2020 | 121,426.00 |
| Jun 30, 2020 | 121,426.00 |
| Mar 31, 2020 | 29,523.00 |
| Mar 31, 2020 | 29,523.00 |
| Dec 31, 2019 | 47,879.00 |
| Dec 31, 2019 | 47,879.00 |
| Mar 31, 2019 | 23,118.00 |
| Mar 31, 2019 | 23,118.00 |
| Dec 31, 2018 | 682.00 |
| Dec 31, 2018 | 682.00 |